These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 27530124
1. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma. Sabet A, Binse I, Dogan S, Koch A, Rosenbaum-Krumme SJ, Biersack HJ, Biermann K, Ezziddin S. Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):190-195. PubMed ID: 27530124 [Abstract] [Full Text] [Related]
2. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer. Sabet A, Binse I, Grafe H, Ezziddin S, Görges R, Poeppel TD, Bockisch A, Rosenbaum-Krumme SJ. Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127 [Abstract] [Full Text] [Related]
3. Clinical and prognostic role of detection timing of distant metastases in patients with differentiated thyroid cancer. Albano D, Panarotto MB, Durmo R, Rodella C, Bertagna F, Giubbini R. Endocrine; 2019 Jan; 63(1):79-86. PubMed ID: 30112608 [Abstract] [Full Text] [Related]
7. Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma. Zhang XY, Sun JW, Qiu ZL, Wang Y, Chen XY, Zhao JH, Luo QY. Endocrine; 2019 Nov; 66(2):254-265. PubMed ID: 31317522 [Abstract] [Full Text] [Related]
9. Prognostic implications of radioiodine avidity and serum thyroglobulin in differentiated thyroid carcinoma with distant metastasis. Kim HJ, Lee JI, Kim NK, Min YK, Kim SW, Chung JH. World J Surg; 2013 Dec; 37(12):2845-52. PubMed ID: 24085223 [Abstract] [Full Text] [Related]
10. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size. Meixner M, Hellmich M, Dietlein M, Kobe C, Schicha H, Schmidt M. Nuklearmedizin; 2013 Dec; 52(3):71-80. PubMed ID: 23483137 [Abstract] [Full Text] [Related]
11. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. Handkiewicz-Junak D, Wloch J, Roskosz J, Krajewska J, Kropinska A, Pomorski L, Kukulska A, Prokurat A, Wygoda Z, Jarzab B. J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106 [Abstract] [Full Text] [Related]
12. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy. Qiu ZL, Shen CT, Luo QY. Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724 [Abstract] [Full Text] [Related]
13. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Jarzab B, Handkiewicz-Junak D, Wloch J. Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322 [Abstract] [Full Text] [Related]
14. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, Sack H. Cancer; 1996 Jan 01; 77(1):172-80. PubMed ID: 8630926 [Abstract] [Full Text] [Related]
19. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables. Gandhi S, Abhyankar A, Basu S. Nucl Med Commun; 2014 Feb 01; 35(2):205-9. PubMed ID: 24217429 [Abstract] [Full Text] [Related]